Approval · Notice of Compliance 32136 · 2023
CLONAPAM: Notice of Compliance 32136
Issued November 20, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32136
- Date
- November 20, 2023
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Labelling Only
- Reason
- Update to the Product Monograph. Product Monograph reformatted to the Master Template.
- Canadian reference product
- RIVOTRIL (Hoffmann-La Roche Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLONAPAM | Not yet assigned | — |
Medicinal ingredients
- CLONAZEPAM 0.5 MG per TAB
- CLONAZEPAM 1 MG per TAB
- CLONAZEPAM 2 MG per TAB